Prevalence and Prognostic Significance of Secondary Lymphedema Following Breast Cancer | Zendy

Sandra C. Hayes | Zendy; Tracey Di Sipio | Zendy; Sheree Rye | Zendy; J. Alejandro López | Zendy; Christobel Saunders | Zendy; Chris Pyke | Zendy; John Bashford | Zendy; Diana Battistutta | Zendy; Beth Newman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prevalence and Prognostic Significance of Secondary Lymphedema Following Breast Cancer

Author(s) -

Sandra C. Hayes,

Tracey Di Sipio,

Sheree Rye,

J. Alejandro López,

Christobel Saunders,

Chris Pyke,

John Bashford,

Diana Battistutta,

Beth Newman

Publication year - 2011

Publication title -

lymphatic research and biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.646

H-Index - 46

eISSN - 1557-8585

pISSN - 1539-6851

DOI - 10.1089/lrb.2011.0007

Subject(s) - lymphedema , medicine , breast cancer , secondary lymphedema , proportional hazards model , population , adverse effect , quality of life (healthcare) , confidence interval , cancer , surgery , oncology , nursing , environmental health

The adverse consequences of lymphedema following breast cancer in relation to physical function and quality of life are clear; however, its potential relationship with survival has not been investigated. Our purpose was to determine the prevalence of lymphedema and associated upper-body symptoms at 6 years following breast cancer and to examine the prognostic significance of lymphedema with respect to overall 6-year survival (OS).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research